Published online Jun 27, 2023. doi: 10.4240/wjgs.v15.i6.1104
Peer-review started: September 30, 2022
First decision: January 3, 2023
Revised: January 29, 2023
Accepted: April 7, 2023
Article in press: April 7, 2023
Published online: June 27, 2023
Processing time: 258 Days and 11.3 Hours
The failure patterns and risk factors for local recurrence and distant metastasis after laparoscopic intersphincteric resection (LsISR) surgery remain controversial and require further investigation.
To investigate the long-term outcomes and failure patterns after LsISR.
Patients with ultralow rectal cancer who underwent LsISR from multicenter between January 2012 and October 2022. We included patients who underwent LsISR surgery.
The Chi-square, Fisher's exact test, or Pearson's correlation test was used to analyze differences between the primary and validation cohorts. Variables with a P-value < 0.100 in the univariate analyses were included in the multivariate analyses. Hazard ratios and 95% confidence intervals of the risk factors were analyzed using multivariate logistic regression.
Local recurrence and distant metastasis occurred in 3.5% and 11.4% of patients, respectively. The overall survival/local recurrence-free survival/distance metastasis-free survival rates at 1, 3, and 5 years were 96.5%/91.3%/87.0%, 98.4%/97.1%/95.4%, and 96.1%/90.1%/82.6%, respectively. LRFS was associated with (y)N + and poor differentiation, whereas the independent prognostic factors for DMFS were lymph node metastasis and (y)pT3 stage.
We confirmed that poor differentiation, (y)pT3 stage, and (y)Pn + were independent risk factors for treatment failure, and thus patients with these factors should be carefully managed with optimal neoadjuvant therapy and surgical strategies.
This research will help clarify the high recurrence risk patients and take up most appropriate perioperative treatment strategies.